The effects and benefits of creatine supplementation on brain health
DOI:
https://doi.org/10.12775/QS.2024.22.54545Keywords
creatine, supplementation, brain health, depression, neurodegenerationAbstract
Introduction: Creatine is a naturally occurring compound vital for energy metabolism, particularly in high-energy-demand tissues like muscles and the brain. Traditionally, research on creatine has focused on its ergogenic effects in sports, but emerging research suggests it may also positively impact brain health. Studies are exploring creatine monohydrate's role in improving cognitive function, mitigating neurodegenerative processes, and supporting mental health. This dual functionality highlights the compound's versatility as both a performance enhancer and a potential therapeutic agent for neurological health. By expanding the scope of creatine research beyond physical performance, we can better understand and utilize its full capabilities to enhance human health. This research review examines the growing evidence suggesting that creatine supplementation could significantly benefit brain health and the management of neurological diseases.
Aim of the study: This review aims to synthesize current findings on creatine's cognitive benefits and its therapeutic potential for neurological disorders, critically analyzing preclinical and clinical studies to identify gaps and suggest future research directions.
Materials and Methods: A comprehensive literature search was conducted using PubMed and Google Scholar databases, covering studies published between 2000 and 2024. Keywords such as creatine supplementation, brain health and neurodegeneration were used. Exclusion criteria included non-peer-reviewed articles, studies with insufficient data, and those not in English.
Conclusions: This review highlights the potential benefits of creatine supplementation for cognitive and neurodegenerative diseases, noting its positive effects on memory, alleviating depression and anxiety, and offering neuroprotection. Future research should aim to standardize dosing, extend follow-up periods, and include larger, more diverse populations.
References
Rackayova V, Cudalbu C, Pouwels PJW, Braissant O. Creatine in the central nervous system: From magnetic resonance spectroscopy to creatine deficiencies. Anal Biochem. 2017;529:144-157. doi:10.1016/J.AB.2016.11.007
Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14(1). doi:10.1186/S12970-017-0173-Z
Rawson ES, Venezia AC. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids. 2011;40(5):1349-1362. doi:10.1007/S00726-011-0855-9
Klein AM, Ferrante RJ. The Neuroprotective Role of Creatine. In: Creatine and Creatine Kinase in Health and Disease. Springer Netherlands; :205-243. doi:10.1007/978-1-4020-6486-9_11
Kious BM, Kondo DG, Renshaw PF. Creatine for the Treatment of Depression. Biomolecules 2019, Vol 9, Page 406. 2019;9(9):406. doi:10.3390/BIOM9090406
Kreider RB. Species-specific responses to creatine supplementation. https://doi.org/101152/ajpregu003752003. 2003;285(4 54-4). doi:10.1152/AJPREGU.00375.2003
Alger AH. 8.2 Creatine.
Demant TW, Rhodes EC. Effects of creatine supplementation on exercise performance. Sports Medicine. 1999;28(1):49-60. doi:10.2165/00007256-199928010-00005/METRICS
Gabr RE, El-Sharkawy AMM, Schär M, Weiss RG, Bottomley PA. High-energy phosphate transfer in human muscle: Diffusion of phosphocreatine. Am J Physiol Cell Physiol. 2011;301(1):234-241. doi:10.1152/AJPCELL.00500.2010/ASSET/IMAGES/LARGE/ZH00051166260005.JPEG
C. Dictionary of Toxicology. Published online 2015:65-104. doi:10.1016/B978-0-12-420169-9.00003-5
Farshidfar F, Pinder MA, Myrie SB. Creatine Supplementation and Skeletal Muscle Metabolism for Building Muscle Mass- Review of the Potential Mechanisms of Action. Curr Protein Pept Sci. 2017;18(12):1273-1287. doi:10.2174/1389203718666170606105108
Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 2011;40(5):1271-1296. doi:10.1007/S00726-011-0877-3/TABLES/1
Kaldis P, Hemmer W, Zanolla E, Holtzman D, Wallimann T. “Hot spots” of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus. Dev Neurosci. 1996;18(5-6):542-554. doi:10.1159/000111452
Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull. 2008;76(4):329-343. doi:10.1016/J.BRAINRESBULL.2008.02.035
Kreider RB, Jäger R, Purpura M. Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review. Nutrients 2022, Vol 14, Page 1035. 2022;14(5):1035. doi:10.3390/NU14051035
Buford TW, Kreider RB, Stout JR, et al. International Society of Sports Nutrition position stand: creatine supplementation and exercise. J Int Soc Sports Nutr. 2007;4:6. doi:10.1186/1550-2783-4-6
Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107-1213. doi:10.1152/PHYSREV.2000.80.3.1107/ASSET/IMAGES/LARGE/9J0300087020.JPEG
Cunha MP, Martín De Saavedra MD, Romero A, et al. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson’s model. ASN Neuro. 2015;6(6). doi:10.1177/1759091414554945/ASSET/IMAGES/LARGE/10.1177_1759091414554945-FIG8.JPEG
Herculano-Houzel S. Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution. PLoS One. 2011;6(3). doi:10.1371/JOURNAL.PONE.0017514
Salomons GS, van Dooren SJM, Verhoeven NM, et al. X-linked creatine transporter defect: An overview. J Inherit Metab Dis. 2003;26(2-3):309-318. doi:10.1023/A:1024405821638
Jost CR, Van der Zee CEEM, In ’t Zandt HJA, et al. Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. Eur J Neurosci. 2002;15(10):1692-1706. doi:10.1046/J.1460-9568.2002.02001.X
Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology. 2011;21(9):655-679. doi:10.1016/J.EURONEURO.2011.07.018
Terlizzi EP, Zablotsky B. Mental Health Treatment Among Adults: United States, 2019. NCHS Data Brief. Published online 2020.
Perou R, Bitsko R, Blumberg SJ, et al. Mental health surveillance among children--United States, 2005-2011. MMWR Suppl. Published online 2013.
Depressive disorder (depression). Accessed July 27, 2024. https://www.who.int/news-room/fact-sheets/detail/depression
Faulkner P, Paioni SL, Kozhuharova P, et al. Relationship between depression, prefrontal creatine and grey matter volume. Journal of Psychopharmacology. 2021;35(12):1464-1472. doi:10.1177/02698811211050550/ASSET/IMAGES/LARGE/10.1177_02698811211050550-FIG4.JPEG
Bakian A V., Huber RS, Scholl L, Renshaw PF, Kondo D. Dietary creatine intake and depression risk among U.S. adults. Translational Psychiatry 2020 10:1. 2020;10(1):1-11. doi:10.1038/s41398-020-0741-x
Lyoo IK, Yoon S, Kim TS, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. American Journal of Psychiatry. 2012;169(9):937-945. doi:10.1176/APPI.AJP.2012.12010009/SUPPL_FILE/APPI.AJP.2012.12010009_DS001.PDF
Kious BM, Sabic H, Sung YH, Kondo DG, Renshaw P. An Open-Label Pilot Study of Combined Augmentation with Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women. J Clin Psychopharmacol. 2017;37(5):578-583. doi:10.1097/JCP.0000000000000754
Levine J, Green T, Osher Y, Karni N, Levine J. Creatine monohydrate in resistant depression: a preliminary study. Bipolar Disord. 2007;9(7):754-758. doi:10.1111/J.1399-5618.2007.00532.X
Kanekar S, Ettaro R, Hoffman MD, et al. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression. International Journal of Molecular Sciences 2021, Vol 22, Page 8195. 2021;22(15):8195. doi:10.3390/IJMS22158195
Pazini FL, Rosa JM, Camargo A, et al. mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test. Chem Biol Interact. 2020;332. doi:10.1016/J.CBI.2020.109281
Anderson JR (John R. Cognitive Psychology and Its Implications. Worth Publishers; 2010.
Eysenck MW, Keane MT. Cognitive Psychology : A Student’s Handbook. Accessed July 25, 2024. https://www.routledge.com/Cognitive-Psychology-A-Students-Handbook/Eysenck-Keane/p/book/9781138482234
Prokopidis K, Giannos P, Triantafyllidis KK, Kechagias KS, Forbes SC, Candow DG. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023;81(4):416-427. doi:10.1093/NUTRIT/NUAC064
Dos Santos FS, Da Silva LA, Pochapski JA, et al. Effects of l-arginine and creatine administration on spatial memory in rats subjected to a chronic variable stress model. Pharm Biol. 2014;52(8):1033-1038. doi:10.3109/13880209.2013.876654
Souza MA, Magni DV, Guerra GP, et al. Involvement of hippocampal CAMKII/CREB signaling in the spatial memory retention induced by creatine. Amino Acids. 2012;43(6):2491-2503. doi:10.1007/S00726-012-1329-4/METRICS
Haris M, Singh A, Cai K, et al. MICEST: A potential tool for non-invasive detection of molecular changes in Alzheimer’s disease. J Neurosci Methods. 2013;212(1):87-93. doi:10.1016/J.JNEUMETH.2012.09.025
Bürklen TS, Schlattner U, Homayouni R, et al. The Creatine Kinase/Creatine Connection to Alzheimer’s Disease: CK Inactivation, APP-CK Complexes, and Focal Creatine Deposits. J Biomed Biotechnol. 2006;2006:1-11. doi:10.1155/JBB/2006/35936
Brewer GJ, Wallimann TW. Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β‐Amyloid in Rat Hippocampal Neurons. J Neurochem. 2000;74(5):1968-1978. doi:10.1046/J.1471-4159.2000.0741968.X
Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomedicine & Pharmacotherapy. 2004;58(1):39-46. doi:10.1016/J.BIOPHA.2003.11.004
Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35-45. doi:10.1016/J.MITO.2019.07.003
Burtscher J, Millet GP. Hypoxia, Acidification and Inflammation: Partners in Crime in Parkinson’s Disease Pathogenesis? Immuno 2021, Vol 1, Pages 78-90. 2021;1(2):78-90. doi:10.3390/IMMUNO1020006
Dionísio PA, Amaral JD, Rodrigues CMP. Oxidative stress and regulated cell death in Parkinson’s disease. Ageing Res Rev. 2021;67:101263. doi:10.1016/J.ARR.2021.101263
Genius J, Geiger J, Bender A, Möller HJ, Klopstock T, Rujescu D. Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration. PLoS One. 2012;7(2):e30554. doi:10.1371/JOURNAL.PONE.0030554
Brustovetsky N, Brustovetsky T, Dubinsky JM. On the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem. 2001;76(2):425-434. doi:10.1046/J.1471-4159.2001.00052.X
Pan JW, Takahashi K. Cerebral energetic effects of creatine supplementation in humans. Am J Physiol Regul Integr Comp Physiol. 2007;292(4). doi:10.1152/AJPREGU.00717.2006/ASSET/IMAGES/LARGE/ZH60040757340004.JPEG
Kostadinova I, Kondeva-Burdina M, Marinov L, Vezenkov LL, Simeonova R. Newly Synthesized Creatine Derivatives as Potential Neuroprotective and Antioxidant Agents on In Vitro Models of Parkinson’s Disease. Life 2023, Vol 13, Page 139. 2023;13(1):139. doi:10.3390/LIFE13010139
Mertschenk B& GC& WT. Health assessment of creatine as a dietary supplement. Published online 2001. Accessed July 25, 2024. https://www.researchgate.net/publication/296817581_Health_assessment_of_creatine_as_a_dietary_supplement
Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res. 2002;42(4):279-285. doi:10.1016/S0168-0102(02)00007-X
Bizzarini E, De Angelis L. Is the use of oral creatine supplementation safe? J Sports Med Phys Fitness. 2004;44(4):411-416.
Persky AM, Rawson ES. Safety of Creatine Supplementation. Subcell Biochem. 2007;46:275-289. doi:10.1007/978-1-4020-6486-9_14
Greenwood M, Farris J, Kreider R, Greenwood L, Byars A. Creatine supplementation patterns and perceived effects in select division I collegiate athletes. Clin J Sport Med. 2000;10(3):191-194. doi:10.1097/00042752-200007000-00007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Elena Sztemberg, Dominik Łepecki, Bartłomiej Grodziński, Robert Tomaszewski, Marcin Mikusek-Pham Van, Karolina Krawiel, Marta Kras, Marek Król, Aleksandra Cieślik, Hanna Gruszczyńska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 239
Number of citations: 0